EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape

Marla Lipsyc-Sharf iD, Sara A Hurvitz iD

Journal of Clinical Oncology · 2026

DOI: 10.1200/jco-26-00672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Oncology, 2026. Verfasst von Marla Lipsyc-Sharf und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Los Angeles, Los Angeles, CA. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past three decades, the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer has undergone a remarkable transformation. Once associated with poor outcomes and a median survival of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesHumansFemaleMolecular Targeted TherapyTrastuzumabProtein Kinase InhibitorsAntineoplastic Agents, Immunological

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanTrastuzumabProtein Kinase InhibitorsAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • University of California, Los Angeles, Los Angeles, CA.
  • Fred Hutchinson Cancer Center, Seattle, WA.

ORCID-Profile: Marla Lipsyc-Sharf, Sara A Hurvitz

Zitieren

APA

Lipsyc-Sharf, M., & Hurvitz, S. A. (2026). Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00672

Vancouver

Lipsyc-Sharf M, Hurvitz SA. Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-00672

BibTeX
@article{LipsycSharf2026,
  author = {Lipsyc-Sharf, Marla and Hurvitz, Sara A},
  title = {Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-26-00672}
}
Kostenlos starten →